US20150148701A1 - Systems and methods for treating tissue regions of the body - Google Patents
Systems and methods for treating tissue regions of the body Download PDFInfo
- Publication number
- US20150148701A1 US20150148701A1 US14/588,858 US201514588858A US2015148701A1 US 20150148701 A1 US20150148701 A1 US 20150148701A1 US 201514588858 A US201514588858 A US 201514588858A US 2015148701 A1 US2015148701 A1 US 2015148701A1
- Authority
- US
- United States
- Prior art keywords
- fluid
- pressure
- tissue
- sensed
- sensing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 239000012530 fluid Substances 0.000 claims abstract description 96
- 238000012800 visualization Methods 0.000 claims abstract description 6
- 210000000111 lower esophageal sphincter Anatomy 0.000 claims description 14
- 210000000746 body region Anatomy 0.000 claims description 6
- 230000000007 visual effect Effects 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 abstract description 14
- 238000012544 monitoring process Methods 0.000 abstract description 9
- 210000001519 tissue Anatomy 0.000 description 66
- 230000002262 irrigation Effects 0.000 description 22
- 238000003973 irrigation Methods 0.000 description 22
- 239000000463 material Substances 0.000 description 15
- 230000003902 lesion Effects 0.000 description 11
- -1 poly(ethylene) Polymers 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- 210000005070 sphincter Anatomy 0.000 description 7
- 210000002318 cardia Anatomy 0.000 description 5
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 238000004891 communication Methods 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000011810 insulating material Substances 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 238000001839 endoscopy Methods 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002991 molded plastic Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000004886 process control Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 239000010963 304 stainless steel Substances 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229910000589 SAE 304 stainless steel Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003000 extruded plastic Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
- A61B5/036—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs by means introduced into body tracts
- A61B5/037—Measuring oesophageal pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7405—Details of notification to user or communication with user or patient ; user input means using sound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/16—Indifferent or passive electrodes for grounding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
- A61B2018/00029—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
- A61B2018/00244—Balloons adapted to separate target tissue from other tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00488—Esophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00494—Stomach, intestines or bowel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00553—Sphincter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00744—Fluid flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00821—Temperature measured by a thermocouple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00863—Fluid flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00982—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00994—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1422—Hook
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1425—Needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1465—Deformable electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1475—Electrodes retractable in or deployable from a housing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B2018/1807—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using light other than laser radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B2034/2046—Tracking techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
Definitions
- the invention is directed to devices, systems and methods for treating tissue regions of the body.
- Catheter-based devices that deploy expandable structures into interior body regions are well known. These structures are typically introduced through a body lumen or vessel in a collapsed, low profile condition. Once at or near the targeted body region, the structures are expanded in situ into an enlarged condition to make contact with tissue.
- the structures can carry operative elements that, when in contact with tissue, perform a therapeutic or diagnostic function. They can, for example, deliver energy to ablate targeted tissue in the region.
- Some of these structures can be expanded by inflation by delivery of fluid into the interior of the structure. It is desirable to control the amount of inflation, so as not to over-inflate the structures. Over-inflation can lead to damage of the structure, or unintended trauma or damage to nearby tissue.
- the invention provides improved systems and methods for treating a tissue region.
- the systems and methods comprise a fluid path having an outlet located at or near the therapeutic or diagnostic element. The location of the outlet places the outlet into a position with respect to the targeted tissue region concurrently with the therapeutic or diagnostic element.
- the systems and methods also include a source of fluid under pressure. The source is in communication with the fluid path to convey fluid under pressure through the fluid path.
- the systems and methods include a fluid pressure sensor, which communicates with the fluid path to sense prevailing fluid pressure in the path.
- the systems and methods also include an output to indicate the sensed prevailing fluid pressure or changes in the sensed prevailing fluid pressure over time. The sensed pressure conditions correlate with the position of the therapeutic or diagnostic element relative to the targeted tissue region.
- the source of fluid conveys air under pressure
- the fluid pressure sensor comprises a manometer.
- changes in tissue pressure at or near the path outlet governs fluid flow in the path and gives rise to changes in fluid pressure within the path.
- Changes in the prevailing fluid pressure can be correlated to the position of the path outlet relative to a targeted tissue region.
- the systems and methods comprise a source of fluid under pressure.
- a supply line communicates with the inflatable structure and the source to convey fluid into the inflatable structure to inflate the inflatable structure for use.
- the systems and methods include a pressure relief valve.
- the pressure relief valve communicates with the supply line.
- the pressure relief valve opens and vents fluid from the supply line when a predetermined pressure condition exists in the supply line. This pressure condition is indicative that a desired interior pressure exists within the inflatable structure. This aspect of the invention assures that the inflatable structure is not subject to over-inflation during use.
- the systems and methods include a pressure sensing element that dynamically senses interior pressure within the inflatable structure and generates an output. The sensing can be accomplished in real time, with an appropriate output generated to provide visual or audible feedback to the operator, and/or provide automated process control feedback based upon the sensed pressure information.
- the use of a dynamic pressure sensing element makes possible the automated inflation of an inflatable body in a straightforward and reliable manner.
- the use of dynamic pressure monitoring and control also facilitates the use of a porous balloon structure.
- the porous balloon structure is inflated to a desired pressure condition by the delivery of a liquid, while a portion of the inflation liquid is discharged through pores in the balloon, to provide a desired flow of irrigation fluid to the tissue region concurrent with inflation.
- FIG. 1 is a schematic view of a system for treating tissue.
- FIG. 2 is an enlarged view of the treatment device, with parts broken away and in section, that is associated with the system shown in FIG. 1 , the treatment device comprising basket structure that carries selectively deployable electrode elements and that expands in response to inflation of an interior balloon structure, FIG. 2 showing the basket in a collapsed condition with the electrode elements retracted.
- FIG. 3 is an enlarged view of the treatment device shown in FIG. 2 , with the basket expanded due to inflation of interior balloon structure and the electrode elements still retracted.
- FIG. 4 is an enlarged view of the treatment device shown in FIG. 2 , with the basket expanded due to inflation of interior balloon structure and the electrode elements extended for use, FIG. 4 also showing the passage of irrigation fluid from the basket to cool the surface tissue while radio-frequency energy is applied by the electrode elements to subsurface tissue.
- FIGS. 5 to 7 are simplified anatomic views showing the use of the treatment device shown in FIGS. 2 to 4 deployed in the region of the lower esophageal sphincter to form an array of lesions.
- FIGS. 8 and 9 show, in simplified anatomic and schematic views, a system and method for sensing the position of the treatment device shown FIGS. 2 to 4 with respect to a targeted tissue region, by sensing fluid pressure in a fluid path having an outlet located at or near the electrode elements.
- FIGS. 10 to 13 show, in perspective views, a system and method for manually inflating the balloon structure in the treatment device shown in FIGS. 2 to 4 while tactilely monitoring the magnitude of the inflation pressure to avoid over-inflation of the balloon structure.
- FIGS. 14 and 15 show, in perspective views, a system and method for manually inflating the balloon structure in the treatment device shown in FIGS. 2 to 4 while using a pressure relief valve to avoid over-inflation of the balloon structure.
- FIG. 16 shows, in a perspective view, a system and method that inflate the balloon structure in the treatment device shown in FIGS. 2 to 4 , while dynamically monitoring pressure conditions within the balloon structure in real time, with an appropriate output generated to provide visual or audible feedback to the operator, and/or provide automated process control feedback based upon the sensed pressure information.
- FIG. 17 shows, in a perspective view, a system and method that automatically inflate the balloon structure in the treatment device shown in FIGS. 2 to 4 by dynamically monitoring pressure conditions within the balloon structure.
- FIG. 18 is a perspective view of a treatment device comprising basket structure that carries selectively deployable electrode elements and that expands in response to inflation of an interior balloon structure with a liquid under the control of the system shown in FIG. 17 , FIG. 18 showing the basket in an inflated condition with the electrode elements extended and the inflation liquid also serving as irrigation fluid discharged through an array of openings formed in the balloon structure.
- This Specification discloses various catheter-based systems and methods for treating dysfunction in various locations in an animal body.
- the various aspects of the invention have application in procedures requiring treatment of sphincters and adjoining tissue regions in the body, or hemorrhoids, or incontinence, or obesity, or restoring compliance to or otherwise tightening interior tissue or muscle regions.
- the systems and methods that embody features of the invention are also adaptable for use with systems and surgical techniques that are not necessarily catheter-based.
- the systems and methods are particularly well suited for treating dysfunctions in the upper gastrointestinal tract, e.g., in the lower esophageal sphincter and adjacent cardia of the stomach. For this reason, the systems and methods will be described in this context. Still, it should be appreciated that the disclosed systems and methods are applicable for use in treating other dysfunctions elsewhere in the body, which are not necessarily sphincter-related.
- a tissue treatment device 10 and associated system 36 are shown in FIG. 1 .
- the device 10 includes a handle 12 made, e.g., from molded plastic.
- the handle 12 carries a flexible catheter tube 14 constructed, for example, by extrusion using standard flexible, medical grade plastic materials, like PebaxTM plastic material, vinyl, nylon, poly(ethylene), ionomer, poly(urethane), poly(amide), and poly(ethylene terephthalate).
- the handle 12 is sized to be conveniently held by a physician, to introduce the catheter tube 14 into the tissue region targeted for treatment.
- the catheter tube 14 may be deployed with or without the use of a guide wire.
- the catheter tube 14 carries on its distal end an operative element 16 .
- the operative element 16 can take different forms and can be used for either therapeutic purposes, or diagnostic purposes, or both.
- the operative element 16 can support, for example, a device for imaging body tissue, such as an endoscope, or an ultrasound transducer.
- the operative element 16 can also support a device to deliver a drug or therapeutic material to body tissue.
- the operative element 16 can also support a device for sensing a physiological characteristic in tissue, such as electrical activity, or for transmitting energy to stimulate tissue or to form lesions in tissue.
- the operative element 16 comprises a three-dimensional basket 18 .
- the basket 18 includes an array of arms 20 .
- the arms 20 are desirably made from extruded or molded plastic, but they could also be formed from stainless steel or nickel titanium alloy. As shown in FIG. 2 , the arms 20 are assembled together between a distal tip 22 and a proximal base element 24 .
- an expandable structure 26 comprising, e.g., a balloon, is located within the basket 18 .
- the expandable balloon structure 26 can be made, e.g., from a Polyethylene Terephthalate (PET) material, or a polyamide (non-compliant) material, or a radiation cross-linked polyethylene (semi-compliant) material, or a latex material, or a silicone material, or a C-Flex (highly compliant) material.
- PET Polyethylene Terephthalate
- Non-compliant materials offer the advantages of a predictable size and pressure feedback when inflated in contact with tissue.
- Compliant materials offer the advantages of variable sizes and shape conformance to adjacent tissue geometries.
- the balloon structure 26 presents a normally, generally collapsed condition, as FIG. 2 shows.
- the basket 18 is also normally collapsed about the balloon structure 26 , presenting a low profile for deployment into the targeted tissue region.
- Expansion of the balloon structure 26 e.g., by the introduction of air through a syringe 32 coupled to a one-way check valve fitting 42 on the handle 12 (see FIG. 3 ), urges the arms 20 of the basket 18 to open and expand, as FIG. 3 shows.
- the force exerted by the balloon structure 26 upon the basket arms 20 when expanded, is sufficient to exert an opening force upon the tissue surrounding the basket 18 .
- the targeted tissue region comprises the lower esophageal sphincter (LES) and cardia of the stomach.
- LES lower esophageal sphincter
- the opening force exerted by the balloon structure 26 serves to dilate the sphincter region, as FIG. 6 shows.
- Each basket arm 20 carries an electrode element 28 .
- a push-pull lever 30 on the handle (see FIG. 4 ) is mechanically coupled through the catheter tube 14 to the electrode elements 28 .
- pushing and pulling on the lever 30 causes the electrode elements 28 to slide within the lumens in the basket arms 20 between a retracted position (shown in the FIG. 3 ) and an extended position (shown in FIG. 4 ).
- the electrode element 28 when extended, projects through an opening 56 in the basket arm.
- the extended electrode element 28 pierces tissue.
- temperature sensing elements 82 e.g., thermocouples
- the electrode elements 28 deliver radio frequency energy, e.g., energy having a frequency in the range of about 400 kHz to about 10 mHz.
- a return path is established, e.g., by an external patch electrode, also called an indifferent electrode.
- the application of radio frequency energy serves to ohmically heat tissue in the vicinity of the electrode elements 28 , to thermally injure the tissue and form the localized sub-surface lesions 164 , which are shown in FIG. 6 .
- tissue heating can be accomplished by other means, e.g., by coherent or incoherent light; heated or cooled fluid; resistive heating; microwave; ultrasound; a tissue heating fluid; or cryogenic fluid.
- the natural healing of subsurface lesions or pattern of subsurface lesions created by the applied energy leads to a physical tightening of the sphincter and/or adjoining cardia and/or a reduction in the compliance of these tissues.
- the subsurface lesions can also result in the interruption of aberrant electrical pathways that may cause spontaneous sphincter relaxation.
- the treatment can restore normal closure function to the sphincter.
- the electrode elements 28 can be formed from various energy transmitting materials. For deployment in the esophagus or cardia of the stomach, the electrode elements 28 are formed, e.g., from nickel titanium. The electrode elements 28 can also be formed from stainless steel, e.g., 304 stainless steel, or a combination of nickel titanium and stainless steel.
- the electrode element 28 may comprise a hybrid of materials comprising stainless steel for the proximal portion and nickel titanium alloy for the distal portion.
- each electrode element 28 can carry an electrical insulating material, except at its distal region, where the radio frequency energy is applied to tissue.
- the presence of the insulating material serves to preserve and protect the mucosal tissue surface from exposure to the radio frequency energy, and, thus, from thermal damage.
- the insulating material can comprise, e.g., a Polyethylene Terephthalate (PET) material, or a polyimide or polyamide material.
- the treatment device 10 desirably operates as part of a system 36 .
- the system 36 includes a generator 38 to supply the treatment energy to the operative element 16 .
- the generator 38 supplies radio frequency energy to the electrodes 28 .
- a cable 40 plugged into the handle 12 electrically couples the electrode elements 28 to the generator 38 .
- Electrode supply wires pass through the catheter tube 14 from the handle to the electrode elements 28 .
- the system 36 can also include certain auxiliary processing equipment.
- the processing equipment comprises an external fluid delivery or irrigation apparatus 44 .
- the fluid delivery apparatus 44 comprises an integrated, self priming peristaltic pump rotor that is carried on a side panel of the generator 38 .
- Other types of non-invasive pumping mechanisms can be used, e.g., a syringe pump, a shuttle pump, or a diaphragm pump.
- a luer fitting 48 on the handle 12 couples to tubing 34 to connect the treatment device 10 to the fluid delivery apparatus 44 .
- Irrigation supply tubing in the catheter tube 14 conveys irrigation fluid through a lumen in each basket arm 20 for discharge through irrigation openings 56 (see FIG. 4 ) by or near the electrode elements 28 . This provides localized cooling of surface tissue.
- the irrigation fluid (designated F in FIG. 4 ) is discharged directly at the base of each electrode element 28 .
- the irrigation fluid is conveyed through the same basket arm lumen and is discharged through the same basket arm opening 56 as the electrode element 28 .
- other irrigation paths can be used.
- the processing equipment desirably includes an aspiration source 46 .
- an aspiration source 46 Another luer fitting 50 on the handle 12 couples tubing to connect the treatment device 10 to the aspiration source 46 .
- the aspiration source 46 draws irrigation fluid discharged by or near the electrodes 28 away from the tissue region.
- the aspiration source 46 can comprise, for example, a vacuum source, which is typically present in a physician's suite.
- the system 36 also desirably includes a controller 52 .
- the controller 52 is linked to the generator 38 and the fluid delivery apparatus 44 .
- the controller 52 which preferably includes an onboard central processing unit, governs the power levels, cycles, and duration that the radio frequency energy is distributed to the electrodes 28 , to achieve and maintain temperature levels appropriate to achieve the desired treatment objectives.
- the controller 52 also desirably governs the delivery of irrigation fluid.
- the controller 52 desirably includes an input/output (I/O) device 54 .
- the I/O device 54 which can employ a graphical user interface, allows the physician to input control and processing variables, to enable the controller to generate appropriate command signals.
- the operative element 16 can be deployed at or near the lower esophageal sphincter (LES) for the purpose of treating GERD.
- LES lower esophageal sphincter
- a physician can use the visualization functions of, e.g., an endoscope to obtain proper position and alignment of the operative element 16 with the LES.
- the physician can expand the balloon structure 16 and extend the electrode elements 16 into piercing contact with tissue at or near the LES.
- Application of ablation energy forms the lesions 164 .
- Retraction of the electrode elements 28 and collapsing of the balloon structure 16 allows the physician to reposition the operative element 16 and perform one or more additional ablation sequences (see FIG. 7 ). In this way, the physician forms a desired pattern of circumferentially and axially spaced lesions 164 at or near the LES and cardia.
- electrode impedance can also be electrically sensed by the controller 52 . A reduction in electrode impedance reflects that the electrode element 28 rests in tissue, compared to when the electrode element 28 is not in contact with tissue.
- the system 36 can include means 58 for assessing position based upon sensed changes in tissue pressure in and surrounding a targeted tissue region.
- the changes in tissue pressure are sensed based upon changes in pressure of a fluid (e.g., air or liquid) that is conveyed at or near the surface of the operative element 16 where tissue contact is intended.
- the means 58 includes means for causing a fluid subject to a pressure to flow in a path that has an outlet located at or near a surface of the operative element 16 intended to make tissue contact. Tissue pressure encountered at or near the path outlet affects pressure exerted on the path outlet and governs fluid flow in the path to varying degrees.
- the means 58 includes means for sensing a fluid pressure in the path. An increase in the prevailing fluid pressure sensed over time correlates with the presence of higher tissue pressures at or near the path outlet.
- the means 58 makes possible the sensing of the location of a remote structure relative to a targeted tissue region without direct or indirect visualization, or without other complicated electrical or mechanical paraphernalia.
- the high pressure zone created by the lower esophageal sphincter is a marker for the targeted tissue region.
- the means 58 includes a pressurized source 60 of air and a manometer 62 .
- the air source 60 and manometer 62 can be part of the controller 52 , or separate components coupled to the system 36 , as FIG. 1 shows.
- the source 60 can provide a fluid other than air, in which case the manometer 62 would comprise a device that would sense the prevailing pressure of the selected fluid.
- the air source 60 and manometer 62 are coupled by tubing 64 to the irrigation supply tubing 34 , which leads to the device 10 .
- An inline valve 66 controls communication between the air source 60 and the tubing 34 .
- pressurized air from the source 60 is conveyed through the irrigation lumens in the basket arms 20 , where they exit through the outlets 56 .
- the flow of pressurized air through this path does not occur when the valve 66 is closed.
- pressurized air can be selectively conveyed through the lumen or lumens when it is desired to assess the location of the basket structure 18 relative to the high pressure zone of the lower esophageal sphincter.
- the manometer 62 senses the air pressure prevailing in the air path 64 and provides an output reflecting the magnitude of the sensed pressure.
- the basket structure 18 is advanced while in a collapsed condition to a location beyond the targeted high tissue pressure zone, which in the illustrated embodiment, is the LES. While the basket structure 18 remains in a collapsed condition, the valve 66 is opened to place the pressurized air source 60 into communication with the irrigation lumens in the basket arms 20 . Pressurized air is conveyed through the lumens, exiting through the openings 56 . The manometer 62 will register a prevailing line pressure.
- the physician draws the basket structure 18 back (see FIG. 9 ).
- the region of the basket structure 18 where the electrodes 28 are carried will eventually be brought into the high pressure zone.
- the increased tissue pressure in this region will impede air flow through the outlet openings 56 and generating a backpressure in the air path 64 .
- the manometer 62 will register an increase in sensed pressure.
- the sensed pressure will decrease accordingly.
- the localized increase in sensed pressure can thus be pin-pointed, which indicates that the electrode region of basket structure 18 is in the high tissue pressure zone and thereby positioned for use.
- the physician turns the valve 66 off.
- the high pressure zone can be marked relative to an external anatomic reference, such as a bite block worn by the patient. Since the outlet ports 56 are coincident with the needle electrode locations, the exact location for delivery of radiofrequency energy is located in this way, without the need for endoscopy (or as an adjunct to endoscopy).
- the physician expands the basket structure 18 and proceeds with the lesion formation sequence.
- the controller 52 can communicate with the manometer 62 (as shown in phantom lines in FIG. 1 ). In this arrangement, the controller 52 can be pre-programmed, e.g., to dynamically display the sensed pressure on the GUI 54 and/or to generate a visual and/or audible output when a threshold pressure indicative of tissue contact is sensed.
- manometer 62 and air pressure source 60 could, alternatively, be coupled to the aspiration supply line. Still alternatively, the manometer 62 can be carried on board the treatment device 10 itself, e.g., in the handle 20 .
- tactile feedback can be used.
- a syringe 32 pre-filled with a pre-established volume of air e.g., 25 cc
- the physician depresses the plunger 50 of the syringe 32 to introduce air from the syringe 32 onto the balloon structure 26 .
- the pre-filled volume of air in the syringe 32 is empirically selected based upon the size and physical properties of the balloon structure 26 . As the balloon structure 26 approaches its desired interior pressure, the physician will tactilely feel progressive resistance to advancement of the plunger 50 .
- the plunger When the balloon structure 26 is at the desired interior pressure, releasing the plunger will allow a finite back flow volume of air from the balloon structure 26 into the syringe 32 (e.g., 3-4 cc) (see FIG. 11 ). As FIG. 11 shows, the push back volume displaces the plunger 50 by a finite amount, providing the physician with direct visual and tactile feedback that the balloon structure 26 has been properly inflated. When plunger push back is observed, the physician responds by advancing the plunger 50 to replace the push back volume (as FIG. 12 shows), placing the balloon structure 26 at its desired inflation pressure. The physician disconnects the syringe 32 from the one-way check valve (as FIG. 13 shows), which thereafter maintains the desired interior pressure in the balloon structure 26 .
- a finite back flow volume of air from the balloon structure 26 into the syringe 32 e.g., 3-4 cc
- a pressure relief valve 68 may be coupled in line with the syringe 32 to the one-way valve fitting 42 .
- the valve 68 is condition to open and vent the inflation fluid (in this case, air) at a predetermined pressure, which is selected to be the desired interior pressure of the balloon structure 26 .
- the relief valve 68 remains closed as the syringe 32 —pre-filled with a pre-established volume of air as already described—is manipulated to convey air into the balloon structure 26 , until the balloon structure 26 reaches the predetermined desired interior pressure. At this time (see FIG. 15 ), the relief valve 68 will open, releasing excess air and venting additional air delivery by the syringe 32 . In this way, further increase in interior pressure within the balloon structure 26 is actively prevented.
- the relief valve 68 can be located within the handle 12 or otherwise carried by the device 10 .
- the relief valve 68 can be located in or on the supply line, as FIG. 14 shows.
- the relief valve can be an integrated part of the controller 52 , coupled by a sensing line to the device 10 .
- the system 36 includes means 70 for dynamically sensing the magnitude of pressure within the balloon structure 26 .
- the means 70 comprises a pressure transducer 70 .
- the pressure transducer 70 can be carried in the handle 20 of the treatment device 10 (as FIG. 16 shows), or it can be integrated into the controller 38 .
- a pressure gauge coupled to the transducer can be used to display the sensed pressure in real time.
- the controller 52 can be programmed to impose maximum pressure limits and generate visual or audible alarm conditions based upon the sensed pressure.
- the inflation of the balloon structure 26 can be placed under the control of the controller 52 , and thereby automated.
- the system includes a source 72 of fluid pressure, which can be air or a liquid like saline.
- the source 72 is coupled to the controller 52 and can be commanded to selectively supply inflation fluid under either positive or negative pressure.
- the source 72 is coupled via a supply line 74 to a supply fitting 80 on the handle 12 . This arrangement replaces the use of a manual syringe and the one-way check valve 42 .
- the supply line 74 includes a control valve 78 , which is coupled to the controller 52 .
- the supply line 74 also includes a pressure relief valve 76 , which is likewise coupled to the controller 52 .
- the controller 52 e.g., in response to a foot switch operated by the physician commands opening of the control valve 78 .
- the controller 52 also commands the supply of the inflation fluid from the source 72 under positive pressure.
- the balloon structure 26 undergoes inflation.
- the transducer 70 dynamically monitors the interior pressure as the balloon structure 26 inflates.
- the controller 52 compares the sensed pressure to a maximum threshold, which can be either preprogrammed in the controller 52 or based upon a selected input by the physician.
- the controller 52 can also be programmed to select the threshold pressure according to the current location of the balloon structure 26 , which can be provided by input from the physician.
- the controller 52 opens the pressure relief valve 76 . Thereafter, the controller 52 toggles the pressure relief valve 76 open and closed to automatically maintain the desired interior inflation pressure at the threshold.
- the controller 52 When it is desired to change the location of the balloon structure 26 , or to withdraw the balloon structure 26 , the controller 52 (e.g., in response to a foot switch operated by the physician) commands drawing negative pressure through the supply line 74 (while also closing the relief valve 76 ), to deflate the balloon structure 26 . If, after repositioning, subsequent lesion formation is desired, the controller 52 (e.g., in response to a foot switch operated by the physician) can again command the supply of inflation fluid under positive pressure from the source 72 , to again inflate the balloon structure 26 under the control of the transducer 70 , as just described.
- the system 36 serves to automatically control the inflation and deflation of the balloon structure 26 , while keeping the balloon pressure within the prescribed limits.
- the system 36 is particularly well suited for use in association with an operative element 18 as shown in FIG. 18 .
- the inflation fluid is a liquid that also serves as an irrigation fluid F.
- the irrigation fluid F is discharged in the vicinity of each electrode element 28 through an array of openings 90 formed in the balloon structure 18 itself.
- the openings 90 can be formed, e.g., by laser drilling, mechanical drilling, or poking with a hot needle. This arrangement eliminates the need for a dedicated irrigation passage and through openings in the basket arms 20 .
- the inflation fluid thereby serves a dual purpose. First, the inflation fluid expands the basket structure 26 carrying the electrode elements 28 , enabling their use. Second, the inflation fluid also serves as an irrigation fluid to cool the targeted tissue region.
- the system 36 provides dynamic pressure monitoring and control of the inflation fluid and irrigation fluid, so that the requirements of simultaneous inflation of the balloon structure 18 and irrigation fluid delivery can be balanced, in order to inflate the balloon structure 18 to the desired pressure while achieving a desired irrigation fluid flow rate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Plasma & Fusion (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Human Computer Interaction (AREA)
- Hematology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Systems and methods deploy a therapeutic or diagnostic element into contact with a body tissue region. The systems and methods can sense position of the therapeutic or diagnostic element relative to a targeted tissue region without direct or indirect visualization, by sensing fluid pressure in a fluid path having an outlet located at or near the therapeutic or diagnostic element. The systems and methods can also inflate the therapeutic or diagnostic element during use, while taking steps to avoid over-inflation and/or while dynamically monitoring the pressure conditions within the expanded element.
Description
- This application is a divisional of copending patent application Ser. No. 12/231,924 filed 8 Sep. 2008, which is a divisional of patent application Ser. No. 11/114,592 filed 26 Apr. 2005, which is a continuation of patent application Ser. No. 10/857,632, filed May 28, 2004, which is a continuation-in-part of U.S. patent application Ser. No. 09/955,915, filed Sep. 19, 2001, now U.S. Pat. No. 6,699,243, which is incorporated herein by reference.
- The invention is directed to devices, systems and methods for treating tissue regions of the body.
- Catheter-based devices that deploy expandable structures into interior body regions are well known. These structures are typically introduced through a body lumen or vessel in a collapsed, low profile condition. Once at or near the targeted body region, the structures are expanded in situ into an enlarged condition to make contact with tissue. The structures can carry operative elements that, when in contact with tissue, perform a therapeutic or diagnostic function. They can, for example, deliver energy to ablate targeted tissue in the region.
- Some of these structures can be expanded by inflation by delivery of fluid into the interior of the structure. It is desirable to control the amount of inflation, so as not to over-inflate the structures. Over-inflation can lead to damage of the structure, or unintended trauma or damage to nearby tissue.
- With structures that are expanded in situ, it is also desirable to ascertain whether the structure actually is in contact with the targeted tissue region. Absent such contact, the desired therapeutic or diagnostic outcome may not be achieved.
- The invention provides improved systems and methods for treating a tissue region.
- One aspect of the invention provides systems and methods for sensing the position of a therapeutic or diagnostic element with respect to a targeted tissue region. The systems and methods comprise a fluid path having an outlet located at or near the therapeutic or diagnostic element. The location of the outlet places the outlet into a position with respect to the targeted tissue region concurrently with the therapeutic or diagnostic element. The systems and methods also include a source of fluid under pressure. The source is in communication with the fluid path to convey fluid under pressure through the fluid path. The systems and methods include a fluid pressure sensor, which communicates with the fluid path to sense prevailing fluid pressure in the path. The systems and methods also include an output to indicate the sensed prevailing fluid pressure or changes in the sensed prevailing fluid pressure over time. The sensed pressure conditions correlate with the position of the therapeutic or diagnostic element relative to the targeted tissue region. In one embodiment, the source of fluid conveys air under pressure, and the fluid pressure sensor comprises a manometer.
- According to this aspect of the invention, changes in tissue pressure at or near the path outlet governs fluid flow in the path and gives rise to changes in fluid pressure within the path. Changes in the prevailing fluid pressure can be correlated to the position of the path outlet relative to a targeted tissue region. This aspect of the invention makes possible the sensing of the position of a remote structure with respect to a targeted tissue region without direct or indirect visualization, or without other complicated electrical or mechanical paraphernalia.
- Another aspect of the invention provides systems and methods for inflating an inflatable structure that carries a therapeutic or diagnostic element. The systems and methods comprise a source of fluid under pressure. A supply line communicates with the inflatable structure and the source to convey fluid into the inflatable structure to inflate the inflatable structure for use. The systems and methods include a pressure relief valve. The pressure relief valve communicates with the supply line. The pressure relief valve opens and vents fluid from the supply line when a predetermined pressure condition exists in the supply line. This pressure condition is indicative that a desired interior pressure exists within the inflatable structure. This aspect of the invention assures that the inflatable structure is not subject to over-inflation during use.
- Another aspect of the invention provides systems and methods for dynamically monitoring pressure conditions within an inflatable structure that carries a therapeutic or diagnostic element. The systems and methods include a pressure sensing element that dynamically senses interior pressure within the inflatable structure and generates an output. The sensing can be accomplished in real time, with an appropriate output generated to provide visual or audible feedback to the operator, and/or provide automated process control feedback based upon the sensed pressure information. The use of a dynamic pressure sensing element makes possible the automated inflation of an inflatable body in a straightforward and reliable manner. The use of dynamic pressure monitoring and control also facilitates the use of a porous balloon structure. The porous balloon structure is inflated to a desired pressure condition by the delivery of a liquid, while a portion of the inflation liquid is discharged through pores in the balloon, to provide a desired flow of irrigation fluid to the tissue region concurrent with inflation.
- Other features and advantages of the inventions are set forth in the following Description and drawings, as well as in the appended claims
-
FIG. 1 is a schematic view of a system for treating tissue. -
FIG. 2 is an enlarged view of the treatment device, with parts broken away and in section, that is associated with the system shown inFIG. 1 , the treatment device comprising basket structure that carries selectively deployable electrode elements and that expands in response to inflation of an interior balloon structure,FIG. 2 showing the basket in a collapsed condition with the electrode elements retracted. -
FIG. 3 is an enlarged view of the treatment device shown inFIG. 2 , with the basket expanded due to inflation of interior balloon structure and the electrode elements still retracted. -
FIG. 4 is an enlarged view of the treatment device shown inFIG. 2 , with the basket expanded due to inflation of interior balloon structure and the electrode elements extended for use,FIG. 4 also showing the passage of irrigation fluid from the basket to cool the surface tissue while radio-frequency energy is applied by the electrode elements to subsurface tissue. -
FIGS. 5 to 7 are simplified anatomic views showing the use of the treatment device shown inFIGS. 2 to 4 deployed in the region of the lower esophageal sphincter to form an array of lesions. -
FIGS. 8 and 9 show, in simplified anatomic and schematic views, a system and method for sensing the position of the treatment device shownFIGS. 2 to 4 with respect to a targeted tissue region, by sensing fluid pressure in a fluid path having an outlet located at or near the electrode elements. -
FIGS. 10 to 13 show, in perspective views, a system and method for manually inflating the balloon structure in the treatment device shown inFIGS. 2 to 4 while tactilely monitoring the magnitude of the inflation pressure to avoid over-inflation of the balloon structure. -
FIGS. 14 and 15 show, in perspective views, a system and method for manually inflating the balloon structure in the treatment device shown inFIGS. 2 to 4 while using a pressure relief valve to avoid over-inflation of the balloon structure. -
FIG. 16 shows, in a perspective view, a system and method that inflate the balloon structure in the treatment device shown inFIGS. 2 to 4 , while dynamically monitoring pressure conditions within the balloon structure in real time, with an appropriate output generated to provide visual or audible feedback to the operator, and/or provide automated process control feedback based upon the sensed pressure information. -
FIG. 17 shows, in a perspective view, a system and method that automatically inflate the balloon structure in the treatment device shown inFIGS. 2 to 4 by dynamically monitoring pressure conditions within the balloon structure. -
FIG. 18 is a perspective view of a treatment device comprising basket structure that carries selectively deployable electrode elements and that expands in response to inflation of an interior balloon structure with a liquid under the control of the system shown inFIG. 17 ,FIG. 18 showing the basket in an inflated condition with the electrode elements extended and the inflation liquid also serving as irrigation fluid discharged through an array of openings formed in the balloon structure. - The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodiments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.
- This Specification discloses various catheter-based systems and methods for treating dysfunction in various locations in an animal body. For example, the various aspects of the invention have application in procedures requiring treatment of sphincters and adjoining tissue regions in the body, or hemorrhoids, or incontinence, or obesity, or restoring compliance to or otherwise tightening interior tissue or muscle regions. The systems and methods that embody features of the invention are also adaptable for use with systems and surgical techniques that are not necessarily catheter-based.
- The systems and methods are particularly well suited for treating dysfunctions in the upper gastrointestinal tract, e.g., in the lower esophageal sphincter and adjacent cardia of the stomach. For this reason, the systems and methods will be described in this context. Still, it should be appreciated that the disclosed systems and methods are applicable for use in treating other dysfunctions elsewhere in the body, which are not necessarily sphincter-related.
- A
tissue treatment device 10 and associatedsystem 36 are shown inFIG. 1 . - The
device 10 includes ahandle 12 made, e.g., from molded plastic. Thehandle 12 carries aflexible catheter tube 14 constructed, for example, by extrusion using standard flexible, medical grade plastic materials, like Pebax™ plastic material, vinyl, nylon, poly(ethylene), ionomer, poly(urethane), poly(amide), and poly(ethylene terephthalate). Thehandle 12 is sized to be conveniently held by a physician, to introduce thecatheter tube 14 into the tissue region targeted for treatment. Thecatheter tube 14 may be deployed with or without the use of a guide wire. - The
catheter tube 14 carries on its distal end anoperative element 16. Theoperative element 16 can take different forms and can be used for either therapeutic purposes, or diagnostic purposes, or both. Theoperative element 16 can support, for example, a device for imaging body tissue, such as an endoscope, or an ultrasound transducer. Theoperative element 16 can also support a device to deliver a drug or therapeutic material to body tissue. Theoperative element 16 can also support a device for sensing a physiological characteristic in tissue, such as electrical activity, or for transmitting energy to stimulate tissue or to form lesions in tissue. - In the embodiment shown in
FIGS. 2 to 4 , theoperative element 16 comprises a three-dimensional basket 18. Thebasket 18 includes an array ofarms 20. Thearms 20 are desirably made from extruded or molded plastic, but they could also be formed from stainless steel or nickel titanium alloy. As shown inFIG. 2 , thearms 20 are assembled together between adistal tip 22 and aproximal base element 24. - As
FIGS. 3 and 4 show, anexpandable structure 26 comprising, e.g., a balloon, is located within thebasket 18. Theexpandable balloon structure 26 can be made, e.g., from a Polyethylene Terephthalate (PET) material, or a polyamide (non-compliant) material, or a radiation cross-linked polyethylene (semi-compliant) material, or a latex material, or a silicone material, or a C-Flex (highly compliant) material. Non-compliant materials offer the advantages of a predictable size and pressure feedback when inflated in contact with tissue. Compliant materials offer the advantages of variable sizes and shape conformance to adjacent tissue geometries. - The
balloon structure 26 presents a normally, generally collapsed condition, asFIG. 2 shows. In this condition, thebasket 18 is also normally collapsed about theballoon structure 26, presenting a low profile for deployment into the targeted tissue region. - Expansion of the
balloon structure 26, e.g., by the introduction of air through asyringe 32 coupled to a one-way check valve fitting 42 on the handle 12 (seeFIG. 3 ), urges thearms 20 of thebasket 18 to open and expand, asFIG. 3 shows. The force exerted by theballoon structure 26 upon thebasket arms 20, when expanded, is sufficient to exert an opening force upon the tissue surrounding thebasket 18. - For the purpose of illustration (see
FIGS. 5 and 6 ), the targeted tissue region comprises the lower esophageal sphincter (LES) and cardia of the stomach. When deployed in this or any sphincter region, the opening force exerted by theballoon structure 26 serves to dilate the sphincter region, asFIG. 6 shows. - Each
basket arm 20 carries anelectrode element 28. A push-pull lever 30 on the handle (seeFIG. 4 ) is mechanically coupled through thecatheter tube 14 to theelectrode elements 28. In use, pushing and pulling on thelever 30 causes theelectrode elements 28 to slide within the lumens in thebasket arms 20 between a retracted position (shown in theFIG. 3 ) and an extended position (shown inFIG. 4 ). AsFIG. 4 shows, theelectrode element 28, when extended, projects through anopening 56 in the basket arm. When deployed in the tissue region (seeFIG. 6 ), theextended electrode element 28 pierces tissue. AsFIG. 4 shows, temperature sensing elements 82 (e.g., thermocouples) are desirably carried by thearms 20 near theelectrode elements 28 to sense tissue temperature conditions. - In a desired arrangement, the
electrode elements 28 deliver radio frequency energy, e.g., energy having a frequency in the range of about 400 kHz to about 10 mHz. A return path is established, e.g., by an external patch electrode, also called an indifferent electrode. In this arrangement, the application of radio frequency energy serves to ohmically heat tissue in the vicinity of theelectrode elements 28, to thermally injure the tissue and form thelocalized sub-surface lesions 164, which are shown inFIG. 6 . Of course, tissue heating can be accomplished by other means, e.g., by coherent or incoherent light; heated or cooled fluid; resistive heating; microwave; ultrasound; a tissue heating fluid; or cryogenic fluid. - In this arrangement, the natural healing of subsurface lesions or pattern of subsurface lesions created by the applied energy leads to a physical tightening of the sphincter and/or adjoining cardia and/or a reduction in the compliance of these tissues. The subsurface lesions can also result in the interruption of aberrant electrical pathways that may cause spontaneous sphincter relaxation. In any event, the treatment can restore normal closure function to the sphincter.
- The
electrode elements 28 can be formed from various energy transmitting materials. For deployment in the esophagus or cardia of the stomach, theelectrode elements 28 are formed, e.g., from nickel titanium. Theelectrode elements 28 can also be formed from stainless steel, e.g., 304 stainless steel, or a combination of nickel titanium and stainless steel. - In this arrangement, the
electrode element 28 may comprise a hybrid of materials comprising stainless steel for the proximal portion and nickel titanium alloy for the distal portion. - The exterior surface of each
electrode element 28 can carry an electrical insulating material, except at its distal region, where the radio frequency energy is applied to tissue. The presence of the insulating material serves to preserve and protect the mucosal tissue surface from exposure to the radio frequency energy, and, thus, from thermal damage. The insulating material can comprise, e.g., a Polyethylene Terephthalate (PET) material, or a polyimide or polyamide material. - As
FIG. 1 shows, thetreatment device 10 desirably operates as part of asystem 36. Thesystem 36 includes agenerator 38 to supply the treatment energy to theoperative element 16. In the illustrated embodiment, thegenerator 38 supplies radio frequency energy to theelectrodes 28. Acable 40 plugged into thehandle 12 electrically couples theelectrode elements 28 to thegenerator 38. Electrode supply wires pass through thecatheter tube 14 from the handle to theelectrode elements 28. - The
system 36 can also include certain auxiliary processing equipment. In the illustrated embodiment, the processing equipment comprises an external fluid delivery orirrigation apparatus 44. In the illustrated embodiment, thefluid delivery apparatus 44 comprises an integrated, self priming peristaltic pump rotor that is carried on a side panel of thegenerator 38. Other types of non-invasive pumping mechanisms can be used, e.g., a syringe pump, a shuttle pump, or a diaphragm pump. - A luer fitting 48 on the
handle 12 couples totubing 34 to connect thetreatment device 10 to thefluid delivery apparatus 44. Irrigation supply tubing in thecatheter tube 14 conveys irrigation fluid through a lumen in eachbasket arm 20 for discharge through irrigation openings 56 (seeFIG. 4 ) by or near theelectrode elements 28. This provides localized cooling of surface tissue. In the illustrated embodiment, the irrigation fluid (designated F inFIG. 4 ) is discharged directly at the base of eachelectrode element 28. In this arrangement, the irrigation fluid is conveyed through the same basket arm lumen and is discharged through the samebasket arm opening 56 as theelectrode element 28. Of course, other irrigation paths can be used. - In this arrangement, the processing equipment desirably includes an
aspiration source 46. Another luer fitting 50 on thehandle 12 couples tubing to connect thetreatment device 10 to theaspiration source 46. Theaspiration source 46 draws irrigation fluid discharged by or near theelectrodes 28 away from the tissue region. Theaspiration source 46 can comprise, for example, a vacuum source, which is typically present in a physician's suite. - The
system 36 also desirably includes acontroller 52. Thecontroller 52 is linked to thegenerator 38 and thefluid delivery apparatus 44. Thecontroller 52, which preferably includes an onboard central processing unit, governs the power levels, cycles, and duration that the radio frequency energy is distributed to theelectrodes 28, to achieve and maintain temperature levels appropriate to achieve the desired treatment objectives. In tandem, thecontroller 52 also desirably governs the delivery of irrigation fluid. - The
controller 52 desirably includes an input/output (I/O)device 54. The I/O device 54, which can employ a graphical user interface, allows the physician to input control and processing variables, to enable the controller to generate appropriate command signals. - In use (see
FIGS. 5 to 7 ), theoperative element 16 can be deployed at or near the lower esophageal sphincter (LES) for the purpose of treating GERD. A physician can use the visualization functions of, e.g., an endoscope to obtain proper position and alignment of theoperative element 16 with the LES. - Once proper position and alignment are achieved (see
FIG. 6 ), the physician can expand theballoon structure 16 and extend theelectrode elements 16 into piercing contact with tissue at or near the LES. Application of ablation energy forms thelesions 164. Retraction of theelectrode elements 28 and collapsing of theballoon structure 16 allows the physician to reposition theoperative element 16 and perform one or more additional ablation sequences (seeFIG. 7 ). In this way, the physician forms a desired pattern of circumferentially and axially spacedlesions 164 at or near the LES and cardia. - It is desirable to be able to confirm that the
basket arms 20 are positioned at or near the targeted tissue region. Direct visualization can be used for this purpose. In addition, or alternatively, electrode impedance can also be electrically sensed by thecontroller 52. A reduction in electrode impedance reflects that theelectrode element 28 rests in tissue, compared to when theelectrode element 28 is not in contact with tissue. - Alternatively, or in combination, the
system 36 can include means 58 for assessing position based upon sensed changes in tissue pressure in and surrounding a targeted tissue region. The changes in tissue pressure are sensed based upon changes in pressure of a fluid (e.g., air or liquid) that is conveyed at or near the surface of theoperative element 16 where tissue contact is intended. The means 58 includes means for causing a fluid subject to a pressure to flow in a path that has an outlet located at or near a surface of theoperative element 16 intended to make tissue contact. Tissue pressure encountered at or near the path outlet affects pressure exerted on the path outlet and governs fluid flow in the path to varying degrees. The correlation between increases in tissue pressure encountered at or near the path outlet and fluid flow through the path gives rise to increases in fluid pressure within the path. The means 58 includes means for sensing a fluid pressure in the path. An increase in the prevailing fluid pressure sensed over time correlates with the presence of higher tissue pressures at or near the path outlet. The means 58 makes possible the sensing of the location of a remote structure relative to a targeted tissue region without direct or indirect visualization, or without other complicated electrical or mechanical paraphernalia. - In the illustrated embodiment, the high pressure zone created by the lower esophageal sphincter is a marker for the targeted tissue region. By sensing the pressure at which fluid is delivered at a slow rate through ports on the
basket arms 20 while moving thebasket structure 18 through the esophagus, the increased tissue pressure in the high pressure zone can be detected as the ports move through the zone. - In the illustrated embodiment (see
FIG. 1 ) themeans 58 includes apressurized source 60 of air and amanometer 62. Theair source 60 andmanometer 62 can be part of thecontroller 52, or separate components coupled to thesystem 36, asFIG. 1 shows. Of course, thesource 60 can provide a fluid other than air, in which case themanometer 62 would comprise a device that would sense the prevailing pressure of the selected fluid. - As shown in
FIG. 1 , theair source 60 andmanometer 62 are coupled by tubing 64 to theirrigation supply tubing 34, which leads to thedevice 10. Aninline valve 66 controls communication between theair source 60 and thetubing 34. When thevalve 66 is opened, pressurized air from thesource 60 is conveyed through the irrigation lumens in thebasket arms 20, where they exit through theoutlets 56. The flow of pressurized air through this path does not occur when thevalve 66 is closed. In this way, pressurized air can be selectively conveyed through the lumen or lumens when it is desired to assess the location of thebasket structure 18 relative to the high pressure zone of the lower esophageal sphincter. Themanometer 62 senses the air pressure prevailing in the air path 64 and provides an output reflecting the magnitude of the sensed pressure. - In use (see
FIG. 8 ), thebasket structure 18 is advanced while in a collapsed condition to a location beyond the targeted high tissue pressure zone, which in the illustrated embodiment, is the LES. While thebasket structure 18 remains in a collapsed condition, thevalve 66 is opened to place thepressurized air source 60 into communication with the irrigation lumens in thebasket arms 20. Pressurized air is conveyed through the lumens, exiting through theopenings 56. Themanometer 62 will register a prevailing line pressure. - With the flow of air established, and with the
basket structure 18 still collapsed, the physician draws thebasket structure 18 back (seeFIG. 9 ). The region of thebasket structure 18 where theelectrodes 28 are carried will eventually be brought into the high pressure zone. The increased tissue pressure in this region will impede air flow through theoutlet openings 56 and generating a backpressure in the air path 64. AsFIG. 9 shows, themanometer 62 will register an increase in sensed pressure. As the physician continues to draw thebasket structure 18 back, above the high pressure zone, the sensed pressure will decrease accordingly. The localized increase in sensed pressure can thus be pin-pointed, which indicates that the electrode region ofbasket structure 18 is in the high tissue pressure zone and thereby positioned for use. The physician turns thevalve 66 off. - Using reference marks on the
catheter tube 14, the high pressure zone can be marked relative to an external anatomic reference, such as a bite block worn by the patient. Since theoutlet ports 56 are coincident with the needle electrode locations, the exact location for delivery of radiofrequency energy is located in this way, without the need for endoscopy (or as an adjunct to endoscopy). The physician expands thebasket structure 18 and proceeds with the lesion formation sequence. - The
controller 52 can communicate with the manometer 62 (as shown in phantom lines inFIG. 1 ). In this arrangement, thecontroller 52 can be pre-programmed, e.g., to dynamically display the sensed pressure on theGUI 54 and/or to generate a visual and/or audible output when a threshold pressure indicative of tissue contact is sensed. - It should be appreciated that the
manometer 62 andair pressure source 60 could, alternatively, be coupled to the aspiration supply line. Still alternatively, themanometer 62 can be carried on board thetreatment device 10 itself, e.g., in thehandle 20. - It is desirable to establish some control mechanism to assure that the
balloon structure 26 is not over-inflated or otherwise subject to over-pressure conditions. This avoids damage to theballoon structure 26, as well as potential injury or trauma to tissue near or in contact with theballoon structure 26. - A. Tactile Control
- In one embodiment (see
FIGS. 10 to 13 ), tactile feedback can be used. In this arrangement, asyringe 32 pre-filled with a pre-established volume of air (e.g., 25 cc) (seeFIG. 10 ) is coupled to the oneway check valve 42 on the handle. The physician depresses theplunger 50 of thesyringe 32 to introduce air from thesyringe 32 onto theballoon structure 26. The pre-filled volume of air in thesyringe 32 is empirically selected based upon the size and physical properties of theballoon structure 26. As theballoon structure 26 approaches its desired interior pressure, the physician will tactilely feel progressive resistance to advancement of theplunger 50. When theballoon structure 26 is at the desired interior pressure, releasing the plunger will allow a finite back flow volume of air from theballoon structure 26 into the syringe 32 (e.g., 3-4 cc) (seeFIG. 11 ). AsFIG. 11 shows, the push back volume displaces theplunger 50 by a finite amount, providing the physician with direct visual and tactile feedback that theballoon structure 26 has been properly inflated. When plunger push back is observed, the physician responds by advancing theplunger 50 to replace the push back volume (asFIG. 12 shows), placing theballoon structure 26 at its desired inflation pressure. The physician disconnects thesyringe 32 from the one-way check valve (asFIG. 13 shows), which thereafter maintains the desired interior pressure in theballoon structure 26. - B. Pressure Relief Valve
- In another embodiment (see
FIG. 14 ), apressure relief valve 68 may be coupled in line with thesyringe 32 to the one-way valve fitting 42. Thevalve 68 is condition to open and vent the inflation fluid (in this case, air) at a predetermined pressure, which is selected to be the desired interior pressure of theballoon structure 26. - In this arrangement, the
relief valve 68 remains closed as thesyringe 32—pre-filled with a pre-established volume of air as already described—is manipulated to convey air into theballoon structure 26, until theballoon structure 26 reaches the predetermined desired interior pressure. At this time (seeFIG. 15 ), therelief valve 68 will open, releasing excess air and venting additional air delivery by thesyringe 32. In this way, further increase in interior pressure within theballoon structure 26 is actively prevented. - The
relief valve 68 can be located within thehandle 12 or otherwise carried by thedevice 10. Alternatively, therelief valve 68 can be located in or on the supply line, asFIG. 14 shows. Still alternatively, the relief valve can be an integrated part of thecontroller 52, coupled by a sensing line to thedevice 10. - C. Real Time Pressure Monitoring
- It may be desirable to dynamically monitor the magnitude of pressure within the
balloon structure 26. For example, different pressure magnitudes may be desired at different locations in the tissue region where the pattern oflesions 164 is formed. In this embodiment, thesystem 36 includesmeans 70 for dynamically sensing the magnitude of pressure within theballoon structure 26. - In the illustrated embodiment (see
FIG. 16 ), themeans 70 comprises apressure transducer 70. Thepressure transducer 70 can be carried in thehandle 20 of the treatment device 10 (asFIG. 16 shows), or it can be integrated into thecontroller 38. - As
FIG. 16 shows, a pressure gauge coupled to the transducer (or a virtual gauge on theGUI 54, whichFIG. 16 shows) can be used to display the sensed pressure in real time. Thecontroller 52 can be programmed to impose maximum pressure limits and generate visual or audible alarm conditions based upon the sensed pressure. - With dynamic monitoring of pressure, the inflation of the
balloon structure 26 can be placed under the control of thecontroller 52, and thereby automated. AsFIG. 17 shows, the system includes asource 72 of fluid pressure, which can be air or a liquid like saline. Thesource 72 is coupled to thecontroller 52 and can be commanded to selectively supply inflation fluid under either positive or negative pressure. Thesource 72 is coupled via asupply line 74 to asupply fitting 80 on thehandle 12. This arrangement replaces the use of a manual syringe and the one-way check valve 42. - The
supply line 74 includes acontrol valve 78, which is coupled to thecontroller 52. Thesupply line 74 also includes apressure relief valve 76, which is likewise coupled to thecontroller 52. - In use, upon positioning of the
balloon structure 26 in a collapsed condition at or near the targeted tissue site, the controller 52 (e.g., in response to a foot switch operated by the physician) commands opening of thecontrol valve 78. Thecontroller 52 also commands the supply of the inflation fluid from thesource 72 under positive pressure. Theballoon structure 26 undergoes inflation. - The
transducer 70 dynamically monitors the interior pressure as theballoon structure 26 inflates. Thecontroller 52 compares the sensed pressure to a maximum threshold, which can be either preprogrammed in thecontroller 52 or based upon a selected input by the physician. Thecontroller 52 can also be programmed to select the threshold pressure according to the current location of theballoon structure 26, which can be provided by input from the physician. When the sensed pressure reaches the selected maximum threshold, thecontroller 52 opens thepressure relief valve 76. Thereafter, thecontroller 52 toggles thepressure relief valve 76 open and closed to automatically maintain the desired interior inflation pressure at the threshold. - When it is desired to change the location of the
balloon structure 26, or to withdraw theballoon structure 26, the controller 52 (e.g., in response to a foot switch operated by the physician) commands drawing negative pressure through the supply line 74 (while also closing the relief valve 76), to deflate theballoon structure 26. If, after repositioning, subsequent lesion formation is desired, the controller 52 (e.g., in response to a foot switch operated by the physician) can again command the supply of inflation fluid under positive pressure from thesource 72, to again inflate theballoon structure 26 under the control of thetransducer 70, as just described. - In this way, the
system 36 serves to automatically control the inflation and deflation of theballoon structure 26, while keeping the balloon pressure within the prescribed limits. - The
system 36 is particularly well suited for use in association with anoperative element 18 as shown inFIG. 18 . In this embodiment, the inflation fluid is a liquid that also serves as an irrigation fluid F. The irrigation fluid F is discharged in the vicinity of eachelectrode element 28 through an array ofopenings 90 formed in theballoon structure 18 itself. Theopenings 90 can be formed, e.g., by laser drilling, mechanical drilling, or poking with a hot needle. This arrangement eliminates the need for a dedicated irrigation passage and through openings in thebasket arms 20. The inflation fluid thereby serves a dual purpose. First, the inflation fluid expands thebasket structure 26 carrying theelectrode elements 28, enabling their use. Second, the inflation fluid also serves as an irrigation fluid to cool the targeted tissue region. In this arrangement, thesystem 36 provides dynamic pressure monitoring and control of the inflation fluid and irrigation fluid, so that the requirements of simultaneous inflation of theballoon structure 18 and irrigation fluid delivery can be balanced, in order to inflate theballoon structure 18 to the desired pressure while achieving a desired irrigation fluid flow rate. - The foregoing is considered as illustrative only of the principles of the invention. Furthermore, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the invention to the exact construction and operation shown and described. While the preferred embodiment has been described, the details may be changed without departing from the invention, which is defined by the claims.
Claims (17)
1-11. (canceled)
12. A method for sensing position of a device relative to a body region based on fluid pressure detection, the method comprising the steps of:
a) providing a device having an operative or diagnostic element, a fluid path to convey fluid, and a fluid outlet to body tissue located at or near the operative or diagnostic element, the fluid outlet communicating with the fluid path to output fluid to the body region;
b) inserting the device into the body region of a patient;
c) providing pressurized fluid through the fluid path of the device to exit the fluid outlet at or near the operative or diagnostic element so the fluid comes into contact with body tissue as the device is moved;
d) sensing fluid pressure in the fluid path to detect impeding of fluid from the fluid outlet to sense a position of the device as increased tissue pressure generates a back pressure in the fluid path from the fluid outlet detectable by the sensor;
e) indicating to a user the sensed fluid pressure or changes in the sensed fluid pressure to provide an indication of the position of the device relative to the body region; and
f) subsequent to step (e) operating the operative or diagnostic element of the device.
13. The method of claim 12 , further comprising the step of expanding an expandable basket of the device after sensing fluid pressure, the fluid pressure sensed when the basket is in a collapsed condition.
14. The method of claim 12 , wherein the step of sensing fluid pressure provides a marker for a high pressure zone created by the lower esophageal sphincter.
15. The method of claim 13 , wherein the step of providing pressurized fluid includes the step of providing pressurized fluid through ports in arms of the expandable basket.
15. The method of claim 12 , further comprising the step of displaying on a graphical user interface the sensed fluid pressure or changes in the sensed fluid pressure.
16. The method of claim 12 , wherein the source of fluid conveys air under pressure, and the fluid pressure is sensed using a manometer.
17. The method of claim 12 , wherein the operative element is adapted to make tissue contact and the outlet is located at or near a surface of the operative element.
18. The method of claim 12 , wherein the step of sensing fluid pressure detects changes in a high pressure zone.
19. The method of claim 18 , wherein the high pressure zone is in the lower esophageal sphincter.
20. The method of claim 18 , further comprising the step of withdrawing the device from the high pressure zone after sensing positioning in the high pressure zone.
21. The method of claim 12 , further comprising the step of generating a visual output when a threshold pressure is sensed.
22. The method of claim 12 , further comprising the step of generating an audible output when a threshold pressure is sensed.
23. The method of claim 12 , wherein the position of the device is determined without visualization.
24. The method of claim 12 , wherein the device includes a valve, and further comprising the step of selectively opening or closing the valve to selectively convey or impede fluid through the outlet and into contact with the tissue as the device is moved.
25. The method of claim 24 , wherein the device includes a basket having arms and the valve enables fluid flow through the arms.
26. The method of claim 12 , wherein the device is inserted beyond the target tissue, and further comprising the step of withdrawing the device toward the target tissue.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/588,858 US20150148701A1 (en) | 2001-09-19 | 2015-01-02 | Systems and methods for treating tissue regions of the body |
US15/669,866 US20170367757A1 (en) | 2001-09-19 | 2017-08-04 | Systems and methods for treating tissue regions of the body |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/955,915 US6699243B2 (en) | 2001-09-19 | 2001-09-19 | Devices, systems and methods for treating tissue regions of the body |
US10/857,632 US20060155261A1 (en) | 2001-09-19 | 2004-05-28 | Systems and methods for treating tissue regions of the body |
US11/114,592 US7422587B2 (en) | 2001-09-19 | 2005-04-26 | Systems and methods for treating tissue regions of the body |
US12/231,924 US20090012421A1 (en) | 2001-09-19 | 2008-09-08 | Systems and methods for treating tissue regions of the body |
US12/925,148 US20110077550A1 (en) | 2001-09-19 | 2010-10-14 | Systems and methods for treating tissue regions of the body |
US14/588,858 US20150148701A1 (en) | 2001-09-19 | 2015-01-02 | Systems and methods for treating tissue regions of the body |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/925,148 Division US20110077550A1 (en) | 2001-09-19 | 2010-10-14 | Systems and methods for treating tissue regions of the body |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/669,866 Continuation US20170367757A1 (en) | 2001-09-19 | 2017-08-04 | Systems and methods for treating tissue regions of the body |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150148701A1 true US20150148701A1 (en) | 2015-05-28 |
Family
ID=34864657
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/857,632 Abandoned US20060155261A1 (en) | 2001-09-19 | 2004-05-28 | Systems and methods for treating tissue regions of the body |
US11/114,592 Expired - Lifetime US7422587B2 (en) | 2001-09-19 | 2005-04-26 | Systems and methods for treating tissue regions of the body |
US12/231,924 Abandoned US20090012421A1 (en) | 2001-09-19 | 2008-09-08 | Systems and methods for treating tissue regions of the body |
US12/925,148 Abandoned US20110077550A1 (en) | 2001-09-19 | 2010-10-14 | Systems and methods for treating tissue regions of the body |
US14/588,858 Abandoned US20150148701A1 (en) | 2001-09-19 | 2015-01-02 | Systems and methods for treating tissue regions of the body |
US15/669,866 Abandoned US20170367757A1 (en) | 2001-09-19 | 2017-08-04 | Systems and methods for treating tissue regions of the body |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/857,632 Abandoned US20060155261A1 (en) | 2001-09-19 | 2004-05-28 | Systems and methods for treating tissue regions of the body |
US11/114,592 Expired - Lifetime US7422587B2 (en) | 2001-09-19 | 2005-04-26 | Systems and methods for treating tissue regions of the body |
US12/231,924 Abandoned US20090012421A1 (en) | 2001-09-19 | 2008-09-08 | Systems and methods for treating tissue regions of the body |
US12/925,148 Abandoned US20110077550A1 (en) | 2001-09-19 | 2010-10-14 | Systems and methods for treating tissue regions of the body |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/669,866 Abandoned US20170367757A1 (en) | 2001-09-19 | 2017-08-04 | Systems and methods for treating tissue regions of the body |
Country Status (1)
Country | Link |
---|---|
US (6) | US20060155261A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018075435A1 (en) * | 2016-10-17 | 2018-04-26 | Prytime Medical Devices, Inc. | Access device with guidewire and related methods |
US11896823B2 (en) | 2017-04-04 | 2024-02-13 | Btl Healthcare Technologies A.S. | Method and device for pelvic floor tissue treatment |
Families Citing this family (127)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
US6358245B1 (en) | 1998-02-19 | 2002-03-19 | Curon Medical, Inc. | Graphical user interface for association with an electrode structure deployed in contact with a tissue region |
US8906010B2 (en) | 1998-02-19 | 2014-12-09 | Mederi Therapeutics, Inc. | Graphical user interface for association with an electrode structure deployed in contact with a tissue region |
US20060095032A1 (en) | 1999-11-16 | 2006-05-04 | Jerome Jackson | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US20040215235A1 (en) | 1999-11-16 | 2004-10-28 | Barrx, Inc. | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US6770080B2 (en) | 2001-04-26 | 2004-08-03 | Fenestra Medical, Inc. | Mechanically registered videoscopic myringotomy/tympanostomy tube placement system |
US7399300B2 (en) | 2001-12-04 | 2008-07-15 | Endoscopic Technologies, Inc. | Cardiac ablation devices and methods |
US7591818B2 (en) | 2001-12-04 | 2009-09-22 | Endoscopic Technologies, Inc. | Cardiac ablation devices and methods |
US7226448B2 (en) * | 2001-12-04 | 2007-06-05 | Estech, Inc. (Endoscopic Technologies, Inc.) | Cardiac treatment devices and methods |
US7617005B2 (en) * | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8347891B2 (en) * | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US6752767B2 (en) | 2002-04-16 | 2004-06-22 | Vivant Medical, Inc. | Localization element with energized tip |
US7150745B2 (en) | 2004-01-09 | 2006-12-19 | Barrx Medical, Inc. | Devices and methods for treatment of luminal tissue |
US10792121B2 (en) * | 2004-09-21 | 2020-10-06 | AirX Bioscience, LLC | Tissue expanders and methods of use |
DK1811914T3 (en) * | 2004-09-21 | 2015-09-28 | Shalon Ventures Inc | Vævsudvidende devices |
US7776035B2 (en) | 2004-10-08 | 2010-08-17 | Covidien Ag | Cool-tip combined electrode introducer |
US7553309B2 (en) | 2004-10-08 | 2009-06-30 | Covidien Ag | Electrosurgical system employing multiple electrodes and method thereof |
US7282049B2 (en) | 2004-10-08 | 2007-10-16 | Sherwood Services Ag | Electrosurgical system employing multiple electrodes and method thereof |
US20070066971A1 (en) * | 2005-09-21 | 2007-03-22 | Podhajsky Ronald J | Method and system for treating pain during an electrosurgical procedure |
US7879031B2 (en) | 2005-09-27 | 2011-02-01 | Covidien Ag | Cooled RF ablation needle |
US20070078453A1 (en) * | 2005-10-04 | 2007-04-05 | Johnson Kristin D | System and method for performing cardiac ablation |
US8702694B2 (en) | 2005-11-23 | 2014-04-22 | Covidien Lp | Auto-aligning ablating device and method of use |
US7997278B2 (en) | 2005-11-23 | 2011-08-16 | Barrx Medical, Inc. | Precision ablating method |
US7959627B2 (en) | 2005-11-23 | 2011-06-14 | Barrx Medical, Inc. | Precision ablating device |
US9125731B2 (en) * | 2006-03-01 | 2015-09-08 | Med-Logics, Inc. | Artificial anterior chamber system |
EP2001384B1 (en) * | 2006-03-31 | 2009-08-26 | Breval S.R.L. | Device for the controlled thermal ablation of tumors by means of high-frequency electromagnetic energy |
EP2010085A1 (en) * | 2006-03-31 | 2009-01-07 | Breval S.R.L. | Device and method for the thermal ablation of tumors by means of high-frequency electromagnetic energy under overpressure conditions |
US20070260240A1 (en) | 2006-05-05 | 2007-11-08 | Sherwood Services Ag | Soft tissue RF transection and resection device |
US9020597B2 (en) | 2008-11-12 | 2015-04-28 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
US7763018B2 (en) | 2006-07-28 | 2010-07-27 | Covidien Ag | Cool-tip thermocouple including two-piece hub |
US9345879B2 (en) * | 2006-10-09 | 2016-05-24 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
US20150224310A1 (en) * | 2006-10-09 | 2015-08-13 | Endostim, Inc. | Device and Implantation System for Electrical Stimulation of Biological Systems |
US9724510B2 (en) | 2006-10-09 | 2017-08-08 | Endostim, Inc. | System and methods for electrical stimulation of biological systems |
US11577077B2 (en) | 2006-10-09 | 2023-02-14 | Endostim, Inc. | Systems and methods for electrical stimulation of biological systems |
US8211099B2 (en) | 2007-01-31 | 2012-07-03 | Tyco Healthcare Group Lp | Thermal feedback systems and methods of using the same |
US8425488B2 (en) | 2007-04-19 | 2013-04-23 | Acclarent, Inc. | System and method for the simultaneous bilateral treatment of target tissues within the ears using a guide block structure |
WO2008137757A1 (en) | 2007-05-04 | 2008-11-13 | Barrx Medical, Inc. | Method and apparatus for gastrointestinal tract ablation for treatment of obesity |
US8784338B2 (en) | 2007-06-22 | 2014-07-22 | Covidien Lp | Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size |
US9486269B2 (en) | 2007-06-22 | 2016-11-08 | Covidien Lp | Electrosurgical systems and cartridges for use therewith |
US8251992B2 (en) | 2007-07-06 | 2012-08-28 | Tyco Healthcare Group Lp | Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation |
WO2009009444A1 (en) | 2007-07-06 | 2009-01-15 | Barrx Medical, Inc. | Ablation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding |
US8646460B2 (en) | 2007-07-30 | 2014-02-11 | Covidien Lp | Cleaning device and methods |
US8273012B2 (en) | 2007-07-30 | 2012-09-25 | Tyco Healthcare Group, Lp | Cleaning device and methods |
US8181995B2 (en) | 2007-09-07 | 2012-05-22 | Tyco Healthcare Group Lp | Cool tip junction |
US8292880B2 (en) | 2007-11-27 | 2012-10-23 | Vivant Medical, Inc. | Targeted cooling of deployable microwave antenna |
US8608739B2 (en) | 2008-07-22 | 2013-12-17 | Covidien Lp | Electrosurgical devices, systems and methods of using the same |
US9662163B2 (en) | 2008-10-21 | 2017-05-30 | Hermes Innovations Llc | Endometrial ablation devices and systems |
US8702620B2 (en) * | 2008-11-03 | 2014-04-22 | G.I. View Ltd. | Remote pressure sensing system and method thereof |
US8712550B2 (en) | 2008-12-30 | 2014-04-29 | Biosense Webster, Inc. | Catheter with multiple electrode assemblies for use at or near tubular regions of the heart |
US9770366B2 (en) | 2009-07-15 | 2017-09-26 | Tusker Medical, Inc. | Tympanic membrane pressure equalization tube delivery system |
US9539146B2 (en) | 2009-07-15 | 2017-01-10 | Tusker Medical, Inc. | Trigger assembly for tympanostomy tube delivery device |
CN102711642B (en) | 2009-09-22 | 2015-04-29 | 麦迪尼治疗公司 | Systems and methods for controlling use and operation of a family of different treatment devices |
US9750563B2 (en) | 2009-09-22 | 2017-09-05 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US9775664B2 (en) | 2009-09-22 | 2017-10-03 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US10386990B2 (en) | 2009-09-22 | 2019-08-20 | Mederi Rf, Llc | Systems and methods for treating tissue with radiofrequency energy |
US9474565B2 (en) | 2009-09-22 | 2016-10-25 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US11896282B2 (en) | 2009-11-13 | 2024-02-13 | Hermes Innovations Llc | Tissue ablation systems and method |
EP2542174A4 (en) | 2010-03-05 | 2013-11-06 | Endostim Inc | Device and implantation system for electrical stimulation of biological systems |
US11717681B2 (en) | 2010-03-05 | 2023-08-08 | Endostim, Inc. | Systems and methods for treating gastroesophageal reflux disease |
JP2014508580A (en) | 2011-01-19 | 2014-04-10 | フラクティル ラボラトリーズ インコーポレイテッド | Devices and methods for treatment of tissue |
US20120232549A1 (en) * | 2011-03-09 | 2012-09-13 | Vivant Medical, Inc. | Systems for thermal-feedback-controlled rate of fluid flow to fluid-cooled antenna assembly and methods of directing energy to tissue using same |
AU2014206157B2 (en) * | 2011-03-09 | 2015-12-24 | Covidien Lp | Systems for thermal-feedback-controlled rate of fluid flow to fluid-cooled antenna assembly and methods of directing energy to tissue using same |
US10335230B2 (en) * | 2011-03-09 | 2019-07-02 | Covidien Lp | Systems for thermal-feedback-controlled rate of fluid flow to fluid-cooled antenna assembly and methods of directing energy to tissue using same |
US10278774B2 (en) | 2011-03-18 | 2019-05-07 | Covidien Lp | Selectively expandable operative element support structure and methods of use |
EP3308830A1 (en) | 2011-04-14 | 2018-04-18 | Endostim, Inc. | Systems and methods for treating gastroesophageal reflux disease |
US9237925B2 (en) | 2011-04-22 | 2016-01-19 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US8663190B2 (en) | 2011-04-22 | 2014-03-04 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US20130053792A1 (en) | 2011-08-24 | 2013-02-28 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US9056185B2 (en) | 2011-08-24 | 2015-06-16 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US9925367B2 (en) | 2011-09-02 | 2018-03-27 | Endostim, Inc. | Laparoscopic lead implantation method |
KR102245697B1 (en) | 2012-02-27 | 2021-04-28 | 프랙틸 래브러토리스 인코포레이티드 | Heat ablation systems,devices and methods for the treatment of tissue |
US8403927B1 (en) | 2012-04-05 | 2013-03-26 | William Bruce Shingleton | Vasectomy devices and methods |
AU2013249043B2 (en) * | 2012-04-19 | 2017-04-27 | Fractyl Health, Inc. | Tissue expansion devices, system and methods |
US20140018888A1 (en) * | 2012-07-16 | 2014-01-16 | Boston Scientific Scimed, Inc. | Flow controlled radiofrequency medical balloon |
WO2014022436A1 (en) | 2012-07-30 | 2014-02-06 | Fractyl Laboratories Inc. | Electrical energy ablation systems, devices and methods for the treatment of tissue |
EP2882362B1 (en) | 2012-08-09 | 2024-01-03 | Fractyl Health, Inc. | Ablation systems, devices and methods for the treatment of tissue |
EP2888000A4 (en) | 2012-08-23 | 2016-07-06 | Endostim Inc | Device and implantation system for electrical stimulation of biological systems |
WO2014055997A1 (en) | 2012-10-05 | 2014-04-10 | Fractyl Laboratories Inc. | Methods, systems and devices for performing multiple treatments on a patient |
US9554849B2 (en) | 2012-10-29 | 2017-01-31 | Ablative Solutions, Inc. | Transvascular method of treating hypertension |
US10945787B2 (en) | 2012-10-29 | 2021-03-16 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US10226278B2 (en) | 2012-10-29 | 2019-03-12 | Ablative Solutions, Inc. | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US9301795B2 (en) | 2012-10-29 | 2016-04-05 | Ablative Solutions, Inc. | Transvascular catheter for extravascular delivery |
US10881458B2 (en) | 2012-10-29 | 2021-01-05 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US9526827B2 (en) | 2012-10-29 | 2016-12-27 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US10736656B2 (en) | 2012-10-29 | 2020-08-11 | Ablative Solutions | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US10286182B2 (en) * | 2012-11-12 | 2019-05-14 | Boston Scientific Scimed, Inc. | Renal catheter shaft design |
WO2014130863A1 (en) | 2013-02-21 | 2014-08-28 | Airxpanders, Inc. | Tissue expanders, implants, and methods of use |
US9498619B2 (en) | 2013-02-26 | 2016-11-22 | Endostim, Inc. | Implantable electrical stimulation leads |
US9320652B2 (en) * | 2013-03-14 | 2016-04-26 | Tusker Medical, Inc. | Features to improve and sense tympanic membrane apposition by tympanostomy tube delivery instrument |
US9681891B2 (en) | 2013-03-14 | 2017-06-20 | Tusker Medical, Inc. | Tympanostomy tube delivery device with cutting dilator |
US9848899B2 (en) * | 2013-03-15 | 2017-12-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure sensing of irrigant backpressure for aligning directional medical devices with target tissue |
US9901394B2 (en) * | 2013-04-04 | 2018-02-27 | Hermes Innovations Llc | Medical ablation system and method of making |
WO2014197632A2 (en) | 2013-06-04 | 2014-12-11 | Fractyl Laboratories, Inc. | Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract |
CN105848708A (en) | 2013-09-03 | 2016-08-10 | 恩多斯蒂姆股份有限公司 | Methods and systems of electrode polarity switching in electrical stimulation therapy |
WO2015038973A1 (en) | 2013-09-12 | 2015-03-19 | Fractyl Laboratories, Inc. | Systems, methods and devices for treatment of target tissue |
US9649125B2 (en) | 2013-10-15 | 2017-05-16 | Hermes Innovations Llc | Laparoscopic device |
US9949652B2 (en) | 2013-10-25 | 2018-04-24 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US9931046B2 (en) | 2013-10-25 | 2018-04-03 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
US10517666B2 (en) | 2013-10-25 | 2019-12-31 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US20150119875A1 (en) * | 2013-10-25 | 2015-04-30 | Ablative Solutions, Inc. | Method and apparatus for sparing pain conducting nerves during renal denervation |
EP3068316B1 (en) | 2013-11-13 | 2019-08-07 | Thixos LLC | Devices and kits for treatment of facet joints |
JP6603660B2 (en) | 2013-11-22 | 2019-11-06 | フラクティル ラボラトリーズ インコーポレイテッド | System, device and method for generating treatment constraints in the gastrointestinal tract |
US10959774B2 (en) | 2014-03-24 | 2021-03-30 | Fractyl Laboratories, Inc. | Injectate delivery devices, systems and methods |
US10736500B2 (en) * | 2014-04-28 | 2020-08-11 | Universidad Del A Sabana | System and method for measuring sensory response of tissue |
US20150342669A1 (en) * | 2014-05-29 | 2015-12-03 | Boston Scientific Scimed, Inc. | Devices and methods for controlled energy delivery to airways |
WO2016011269A1 (en) | 2014-07-16 | 2016-01-21 | Fractyl Laboratories, Inc. | Methods and systems for treating diabetes and related diseases and disorders |
US9844641B2 (en) | 2014-07-16 | 2017-12-19 | Fractyl Laboratories, Inc. | Systems, devices and methods for performing medical procedures in the intestine |
US11185367B2 (en) | 2014-07-16 | 2021-11-30 | Fractyl Health, Inc. | Methods and systems for treating diabetes and related diseases and disorders |
US20160038341A1 (en) | 2014-08-08 | 2016-02-11 | Acclarent, Inc. | Tympanostomy tube delivery device with elastomeric brake |
US10195086B2 (en) | 2014-08-11 | 2019-02-05 | Tusker Medical, Inc. | Tympanostomy tube delivery device with rotatable |
US9833360B2 (en) | 2014-08-12 | 2017-12-05 | Tusker Medical, Inc. | Tympanostomy tube delivery device with replaceable shaft portion |
US9833359B2 (en) | 2014-08-12 | 2017-12-05 | Tusker Medical, Inc. | Tympanostomy tube delivery device with cutter force clutch |
EP3220999A2 (en) | 2014-11-17 | 2017-09-27 | Endostim, Inc. | Implantable electro-medical device programmable for improved operational life |
AU2016262085B2 (en) | 2015-05-12 | 2020-10-22 | National University Of Ireland Galway | Devices for therapeutic nasal neuromodulation and associated methods and systems |
US11039755B2 (en) * | 2015-12-03 | 2021-06-22 | Robert S. Katz | Methods and systems for diagnosing and treating fibromyalgia |
CN106053115B (en) * | 2016-07-18 | 2018-08-28 | 合肥凯利光电科技有限公司 | The industrial detection method of job stability in the warm and humid environment of digestive tract power detector |
WO2018094207A1 (en) | 2016-11-17 | 2018-05-24 | Endostim, Inc. | Modular stimulation system for the treatment of gastrointestinal disorders |
US11497507B2 (en) | 2017-02-19 | 2022-11-15 | Orpheus Ventures, Llc | Systems and methods for closing portions of body tissue |
WO2018222372A1 (en) * | 2017-05-30 | 2018-12-06 | Cryterion Medical, Inc. | Cryoballoon deflation assembly and method |
US10849685B2 (en) | 2018-07-18 | 2020-12-01 | Ablative Solutions, Inc. | Peri-vascular tissue access catheter with locking handle |
US11684414B2 (en) | 2018-12-11 | 2023-06-27 | Neurent Medical Limited | Systems and methods for therapeutic nasal neuromodulation |
US11554214B2 (en) | 2019-06-26 | 2023-01-17 | Meditrina, Inc. | Fluid management system |
US11883091B2 (en) | 2020-04-09 | 2024-01-30 | Neurent Medical Limited | Systems and methods for improving sleep with therapeutic nasal treatment |
WO2021205230A1 (en) | 2020-04-09 | 2021-10-14 | Neurent Medical Limited | Systems and methods for therapeutic nasal treatment |
CN113995501A (en) * | 2021-05-25 | 2022-02-01 | 圣犹达医疗用品心脏病学部门有限公司 | System and method for electroporation device incorporating basket and balloon |
WO2023021429A1 (en) * | 2021-08-17 | 2023-02-23 | Fisher & Paykel Healthcare Limited | Apparatus for supplying fluid to a tissue area |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4809710A (en) * | 1988-01-11 | 1989-03-07 | Williamson Jeffrey L | Multilumen manometer catheter |
US20030014046A1 (en) * | 1998-01-14 | 2003-01-16 | Conway-Stuart Medical, Inc. | Sphincter treatment device |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4367740A (en) * | 1980-12-10 | 1983-01-11 | Evanoski Iii Constant J | Combination catheter cystometer system and gastric feeding device |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4621646A (en) * | 1983-12-15 | 1986-11-11 | The United States Of America As Represented By The Secretary Of The Army | Blood flow measuring method |
US4955377A (en) * | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US4981470A (en) * | 1989-06-21 | 1991-01-01 | Synectics Medical, Inc. | Intraesophageal catheter with pH sensor |
US5122137A (en) * | 1990-04-27 | 1992-06-16 | Boston Scientific Corporation | Temperature controlled rf coagulation |
US5233515A (en) * | 1990-06-08 | 1993-08-03 | Cosman Eric R | Real-time graphic display of heat lesioning parameters in a clinical lesion generator system |
US5117827A (en) * | 1990-10-26 | 1992-06-02 | Sandhill Scientific, Inc. | Apparatus and method for ambulatory reflux monitoring |
US5342298A (en) * | 1992-07-31 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Automated fluid pressure control system |
US5334193A (en) * | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
US5348554A (en) * | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5628771A (en) * | 1993-05-12 | 1997-05-13 | Olympus Optical Co., Ltd. | Electromagnetic-wave thermatological device |
WO1994028809A1 (en) * | 1993-06-10 | 1994-12-22 | Imran Mir A | Transurethral radio frequency ablation apparatus |
US5433216A (en) * | 1993-06-14 | 1995-07-18 | Mountpelier Investments, S.A. | Intra-abdominal pressure measurement apparatus and method |
US6056744A (en) * | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US6092528A (en) * | 1994-06-24 | 2000-07-25 | Edwards; Stuart D. | Method to treat esophageal sphincters |
US6006755A (en) * | 1994-06-24 | 1999-12-28 | Edwards; Stuart D. | Method to detect and treat aberrant myoelectric activity |
US6733495B1 (en) * | 1999-09-08 | 2004-05-11 | Curon Medical, Inc. | Systems and methods for monitoring and controlling use of medical devices |
US6464689B1 (en) * | 1999-09-08 | 2002-10-15 | Curon Medical, Inc. | Graphical user interface for monitoring and controlling use of medical devices |
US6044846A (en) * | 1994-06-24 | 2000-04-04 | Edwards; Stuart D. | Method to treat esophageal sphincters |
US5573007A (en) * | 1994-08-08 | 1996-11-12 | Innerspace, Inc. | Gas column pressure monitoring catheters |
SE508792C2 (en) * | 1994-11-21 | 1998-11-09 | Wallsten Medical Sa | Balloon catheter for performing heat treatment in a body cavity or duct |
SE505332C2 (en) * | 1995-05-18 | 1997-08-11 | Lund Instr Ab | Device for heat treatment of body tissue |
US7452358B2 (en) * | 1996-01-05 | 2008-11-18 | Thermage, Inc. | RF electrode assembly for handpiece |
US5957920A (en) * | 1997-08-28 | 1999-09-28 | Isothermix, Inc. | Medical instruments and techniques for treatment of urinary incontinence |
US6464697B1 (en) * | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
US6514249B1 (en) * | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US6790207B2 (en) * | 1998-06-04 | 2004-09-14 | Curon Medical, Inc. | Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract |
US6645201B1 (en) * | 1998-02-19 | 2003-11-11 | Curon Medical, Inc. | Systems and methods for treating dysfunctions in the intestines and rectum |
US7468060B2 (en) * | 1998-02-19 | 2008-12-23 | Respiratory Diagnostic, Inc. | Systems and methods for treating obesity and other gastrointestinal conditions |
US6802841B2 (en) * | 1998-06-04 | 2004-10-12 | Curon Medical, Inc. | Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction |
WO2001017452A1 (en) * | 1999-09-08 | 2001-03-15 | Curon Medical, Inc. | System for controlling a family of treatment devices |
JP2003523225A (en) * | 1999-09-08 | 2003-08-05 | キューロン メディカル,インコーポレイテッド | Systems and methods for monitoring and controlling use of medical devices |
US6547776B1 (en) * | 2000-01-03 | 2003-04-15 | Curon Medical, Inc. | Systems and methods for treating tissue in the crura |
US6544226B1 (en) * | 2000-03-13 | 2003-04-08 | Curon Medical, Inc. | Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body |
US6623452B2 (en) * | 2000-12-19 | 2003-09-23 | Scimed Life Systems, Inc. | Drug delivery catheter having a highly compliant balloon with infusion holes |
US7160270B2 (en) * | 2001-03-26 | 2007-01-09 | Curon Medical, Inc. | Systems and methods employing a bite block insert for positioning and stabilizing external instruments deployed within the body |
US6699243B2 (en) * | 2001-09-19 | 2004-03-02 | Curon Medical, Inc. | Devices, systems and methods for treating tissue regions of the body |
US7077841B2 (en) * | 2001-03-26 | 2006-07-18 | Curon Medical, Inc. | Systems and methods employing a guidewire for positioning and stabilizing external instruments deployed within the body |
EP1435218A1 (en) * | 2002-12-05 | 2004-07-07 | Interuniversitair Microelektronica Centrum Vzw | Method and device for locating visceral constrictions |
US7374547B2 (en) * | 2003-04-25 | 2008-05-20 | Medtronic, Inc. | Delivery device for an acidity monitoring system |
-
2004
- 2004-05-28 US US10/857,632 patent/US20060155261A1/en not_active Abandoned
-
2005
- 2005-04-26 US US11/114,592 patent/US7422587B2/en not_active Expired - Lifetime
-
2008
- 2008-09-08 US US12/231,924 patent/US20090012421A1/en not_active Abandoned
-
2010
- 2010-10-14 US US12/925,148 patent/US20110077550A1/en not_active Abandoned
-
2015
- 2015-01-02 US US14/588,858 patent/US20150148701A1/en not_active Abandoned
-
2017
- 2017-08-04 US US15/669,866 patent/US20170367757A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4809710A (en) * | 1988-01-11 | 1989-03-07 | Williamson Jeffrey L | Multilumen manometer catheter |
US20030014046A1 (en) * | 1998-01-14 | 2003-01-16 | Conway-Stuart Medical, Inc. | Sphincter treatment device |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018075435A1 (en) * | 2016-10-17 | 2018-04-26 | Prytime Medical Devices, Inc. | Access device with guidewire and related methods |
US11896823B2 (en) | 2017-04-04 | 2024-02-13 | Btl Healthcare Technologies A.S. | Method and device for pelvic floor tissue treatment |
Also Published As
Publication number | Publication date |
---|---|
US20110077550A1 (en) | 2011-03-31 |
US20050187546A1 (en) | 2005-08-25 |
US20170367757A1 (en) | 2017-12-28 |
US7422587B2 (en) | 2008-09-09 |
US20090012421A1 (en) | 2009-01-08 |
US20060155261A1 (en) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20170367757A1 (en) | Systems and methods for treating tissue regions of the body | |
US20230122245A1 (en) | Systems and methods for treating tissue with radiofrequency eneregy | |
US9539052B2 (en) | Sphincter treatment apparatus | |
US7125407B2 (en) | Sphincter treatment apparatus | |
US8758340B2 (en) | Applicator system for deploying electrodes | |
US8888774B2 (en) | Methods for treating the cardia of the stomach | |
US9351787B2 (en) | Sphincter treatment apparatus | |
EP3122413B1 (en) | Injectate delivery devices | |
US20170007324A1 (en) | Injectate delivery devices, systems and methods | |
US20150238247A1 (en) | Systems and methods for treating tissue with radiofrequency energy | |
US20030153905A1 (en) | Selective ablation system | |
WO2000066019A1 (en) | Vacuum-assisted systems and methods for treating sphincters and adjoining tissue regions | |
WO2000066016A1 (en) | Systems and methods for forming composite lesions to treat dysfunction in sphincters and adjoining tissue regions | |
WO2000066020A1 (en) | Assemblies to visualize and treat sphincters and adjoining tissue regions | |
US20240189020A1 (en) | Systems and methods for treating tissue with radiofrequency eneregy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: MEDERI RF, LLC, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HORIZON CREDIT II LLC;REEL/FRAME:046069/0567 Effective date: 20180424 Owner name: HORIZON CREDIT II LLC, CONNECTICUT Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDERI THERAPEUTICS INC.;REEL/FRAME:046076/0317 Effective date: 20180424 |